Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

VANFLYTA 17.7 mg film-coated tablets {equilateral_black_triangle}

Active Ingredient:
quizartinib dihydrochloride
Company:  
Daiichi Sankyo UK Limited See contact details
ATC code: 
L01EX11
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 14 Mar 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Daiichi Sankyo UK Limited
Company image
Address
1st Floor, Building 4, Uxbridge Business Park, Sanderson Road, Uxbridge, UB8 1DH, UK
Telephone
+44 (0) 800 028 5122
Medical Information Direct Line
+44 (0) 800 028 5122
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 800 028 5122
Out of Hours Telephone
+44 (0) 800 028 5122